Impilo Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Impilo Therapeutics General Information

Description

Operator of a drug discovery and development company intended to focus on nucleic acid-based medicines to effectively treat solid tumor cancers. The company's platform provides a tumor-targeted tissue penetration capability to specifically enhance nucleic acid drug delivery to tumors, enabling medical professionals to treat solid tumor cancers.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1286 University Avenue
  • Suite 362
  • San Diego, CA 92103
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 1286 University Avenue
  • Suite 362
  • San Diego, CA 92103
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Impilo Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Impilo Therapeutics‘s full profile, request access.

Request a free trial

Impilo Therapeutics Patents

Impilo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024097310-A2 Targeted non-charged-nucleic acid (ncna) delivery and related tumor penetrating nanocomplexes Inactive 01-Nov-2022
WO-2024097310-A3 Targeted non-charged-nucleic acid (ncna) delivery and related tumor penetrating nanocomplexes Inactive 01-Nov-2022

Impilo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Impilo Therapeutics FAQs

  • When was Impilo Therapeutics founded?

    Impilo Therapeutics was founded in 2019.

  • Where is Impilo Therapeutics headquartered?

    Impilo Therapeutics is headquartered in San Diego, CA.

  • What is the size of Impilo Therapeutics?

    Impilo Therapeutics has 2 total employees.

  • What industry is Impilo Therapeutics in?

    Impilo Therapeutics’s primary industry is Drug Discovery.

  • Is Impilo Therapeutics a private or public company?

    Impilo Therapeutics is a Private company.

  • What is Impilo Therapeutics’s current revenue?

    The current revenue for Impilo Therapeutics is .

  • When was Impilo Therapeutics acquired?

    Impilo Therapeutics was acquired on 21-Sep-2020.

  • Who acquired Impilo Therapeutics?

    Impilo Therapeutics was acquired by Cend Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process